Healthy Aging Health Center
This article is from the WebMD News Archive
Muscle Loss Slower in Women Than Men?
March 25, 2008 -- Women aged 65 and older may have a muscle advantage over men their age.
New research shows that women in that age range make more muscle protein most of the day than men.
Exercise Videos
Related Slideshows
There's an exception. Feeding boosts muscle protein synthesis in men but not in women, note the researchers, who included Bettina Mittendorfer, PhD, of Washington University in St. Louis.
But most of the day isn't spent eating. So Mittendorfer's team argues that their findings may "partially explain the slower loss of muscle in older women."
"However," Mittendorfer tells WebMD via email, "one thing to consider is that women start out with less muscle mass so that overall they are probably at greater risk to reach a threshold of muscle loss that leads to functional disabilities. Their lack of response to food [in terms of making muscle protein] is a big problem for the prevention of age-associated loss of muscle mass."
The researchers studied 13 men and 16 women aged 65-80. Participants got muscle biopsies before and after drinking a liquid meal replacement.
Here's a key point that put all of their muscles at risk: None of the participants got regular exercise. Man or woman, young or old, that doesn't bode well for muscle strength.
Muscle loss picks up its pace with age. Exercise, especially strength training, builds muscle. It's never too late to start, but do check with your doctor first.
"Exercise [both strength and endurance] is obviously very important for preserving muscle mass and function as good as possible," writes Mittendorfer. "So far we only have preliminary data for this, but it looks like as with eating, old women do not gain as much muscle from working out as men do. Thus, it is particularly important for women to engage in exercise and eat well and enough protein ... to help keep their muscles."
The study appears in Public Library of Science One.
del.icio.us
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
